Murphy Oil (MUR) shares have increased 0.8% since its last earnings report, underperforming the S&P 500, with consensus estimates trending downward, shifting -38.8% over the past month. The stock currently holds a Zacks Rank #5 (Strong Sell), indicating expectations of below-average returns in the coming months, while Coterra Energy (CTRA), another stock in the same industry, has gained 7.4% over the past month.
Murphy Oil (MUR) has demonstrated recent underperformance, with its shares appreciating only 0.8% since its last earnings report, a period during which it lagged the S&P 500. This subdued stock performance is accompanied by a significant deterioration in analyst outlook, evidenced by a substantial -38.8% downward revision in the consensus earnings estimate over the past month. While Murphy Oil scores a B for value, its overall VGM Score is a C, negatively impacted by a C in Growth and a particularly weak F in Momentum. Reflecting these concerns, Murphy Oil currently holds a Zacks Rank #5 (Strong Sell), indicating an expectation of below-average returns from the stock in the coming months. In comparison, Coterra Energy (CTRA), another company in the Zacks Oil and Gas - Exploration and Production - United States industry, has exhibited stronger recent share performance, gaining 7.4% over the past month. The article also provides financial details for Cabot (identified in provided signals as ticker CBT), noting its last reported quarterly revenues of $1.9 billion, representing a year-over-year increase of 32.9%, and an EPS of $0.80, up from $0.51 a year ago. For the current quarter, Cabot is projected to achieve an EPS of $0.55, a 48.7% year-over-year increase. However, Cabot's Zacks Consensus Estimate has also experienced a downward revision of -9.9% in the last 30 days, contributing to its Zacks Rank #3 (Hold) and a VGM Score of B.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.60
Ticker Sentiment